Observed Signal · Jul 30, 2026 · Funding · Source: techcrunch · Impact: 2/5 · Sentiment: Positive
Fundraising Market: Simile Raises $200M Series B at $2B Valuation
Simile, a startup that builds synthetic/simulated users for marketing and product research, raised $200 million in a Series B at a $2 billion valuation. The round, announced July 30, 2026, was led by Greenoaks with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures. The raise comes five months after Simile's $100 million Series A led by Index. Simile was founded by Joon Sung Park and counts CVS among its customers. The company positions its technology as a way to simulate user behavior for research and product testing, attracting growing VC interest in the synthetic-user market.
Significant VC investment highlights investor interest in synthetic-user technology and potential implications for market research and advertising, but it is not a major platform policy or technical change.
Wichtigste Kernpunkte & Evidenz
- Simile closed a $200 million Series B at a $2 billion valuation (announced 2026-07-30).
- The Series B was led by Greenoaks with participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures.
- The raise comes five months after Simile announced a $100 million Series A led by Index Ventures.
- Simile provides simulated/synthetic users for marketing and product research and lists CVS as a marquee customer.
- Simile was founded by Stanford PhD graduate Joon Sung Park (founder and CEO).
Verknüpfte Unternehmen
3 verknüpfte UnternehmenBain Capital Ventures
Multi-Phase-Venture-Capital-Fonds, der gezielt in wachstumsstarke Technologie-Start-ups investiert.
“The B round was led by Greenoaks with participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventu...”
Greenoaks
Investor / PEEin fokussierter, langfristig orientierter Venture-Capital- und Growth-Equity-Investor in führende Technologie- und Internetunternehmen.
“The B round was led by Greenoaks with participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventu...”
Index Ventures
Eine führende Risikokapitalgesellschaft, die in wegweisende Technologieunternehmen investiert.
“Just five months after emerging from stealth and announcing a $100 million Series A led by Index Ventures, it has closed a $200 million Seri...”
Ontology Mapping & Concepts
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.